论文部分内容阅读
背景及目的:紫杉醇和卡铂每3周给药1次是晚期卵巢癌的标准治疗方案。在该方案的基础上加用其它药物以提高患者存活率的结果令人失望。本研究比较了密集给药方案与传统的紫杉醇和卡铂方案对晚期卵巢癌的疗效。
BACKGROUND & AIM: Paclitaxel and carboplatin administered once every 3 weeks are the standard treatment for advanced ovarian cancer. The results of adding other drugs to increase patient survival based on this regimen have been disappointing. This study compared intensive treatment regimens with conventional paclitaxel and carboplatin regimens in patients with advanced ovarian cancer.